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Objectives. We sought to determine the clinical and echocar-
diographic parameters that differentiate thrombus from pannus
formation as the etiology of obstructed mechanical prosthetic
valves.
Background. Distinction of thrombus from pannus on ob-
structed prosthetic valves is essential because thrombolytic ther-
apy has emerged as an alternative to reoperation.
Methods. We analyzed clinical, transthoracic and transesoph-
ageal echocardiography (TEE) data in 23 patients presenting with
24 obstructed prosthetic valves and compared the findings to
pathology at surgery.
Results. Fourteen valves had thrombus and 10 had pannus
formation. Patients with thrombus had a shorter duration from
time of valve insertion to malfunction, shorter duration of symp-
toms, but similar New York Heart Association functional class at
the time of operation. Patients with thrombus had a lower rate of
adequate anticoagulation (21% vs. 89%; p 5 0.0028). Pannus
formation was more common in the aortic position (70% vs. 21%;
p 5 0.035). Abnormal prosthetic valve motion was detected by
TEE in all cases with thrombus formation but in 60% with pannus
(p 5 0.0198). Thrombi were larger than pannuses (total length
2.8 6 2.47 cm vs. 1.17 6 0.43 cm; p 5 0.038). This was mostly due
to extension of thrombi into the left atrium in prosthetic mitral
valves. Thrombi appeared as a soft mass on the valve in 92% of
cases, whereas 29% of pannuses had a soft echo density (p 5
0.007). Ultrasound video intensity ratio, derived as the video-
intensity of the mass to that of the prosthetic valve, was lower in
the thrombus group (0.46 6 0.14 vs. 0.71 6 0.17, p 5 0.006). A
videointensity ratio of <0.70 had a positive predictive value of 87%
and a negative predictive value of 89% for thrombus. Duration
from onset of symptoms to reoperation of <1 month separated
thrombus from pannus formation. The best objective clinical
parameter for prediction of thrombus was inadequate anticoagu-
lation, whereas the best TEE parameters were qualitative and
quantitative ultrasound intensity of the mass. The presence of
either inadequate anticoagulation or a soft mass by TEE improved
the predictive power of either parameter alone and was similar to
that of ultrasound videointensity ratio.
Conclusions. Duration of symptoms, anticoagulation status and
qualitative and quantitative ultrasound intensity of the mass
obstructing a mechanical prosthetic valve can help differentiate
pannus formation from thrombus and may therefore be of value in
refining the selection of patients for thrombolytic therapy of
prosthetic valve obstruction.
(J Am Coll Cardiol 1998;32:1410–7)
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Since 1960 when the first intracardiac mechanical prostheses
were implanted, a considerable improvement in valve design
resulted in a decrease in prosthetic valve complications. De-
spite these innovations, thrombogenicity of prosthetic valves
remains the most common problem, estimated from 0.1% to
4% per year, depending on valve site, type and adequacy of
anticoagulation (1). Clinical manifestations of this entity range
between embolism, valve obstruction or regurgitation (1–4).
Valve dysfunction may also be the result of fibrous tissue
ingrowth or pannus formation (5–8). Recently, thrombolytic
therapy has emerged as a successful alternative to reoperation
in selected cases of thrombosed prosthetic valves (9–15).
Therefore, the distinction between pannus and thrombus
formation as the underlying etiology of valve dysfunction is
essential. While a history of poor anticoagulation may be
predictive of thrombus formation, distinction between throm-
bus formation and pannus based on clinical grounds may be
difficult and does not necessarily predict success of thrombol-
ysis. Furthermore, traditional methods of fluoroscopy to eval-
uate valve motion and cardiac catheterization for valve hemo-
dynamics do not provide the means to assess the underlying
etiology of valve obstruction.
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Doppler echocardiography is currently the noninvasive
method of choice for evaluating prosthetic valve function
(16–20). Transthoracic echocardiography (TTE) is, however,
limited in assessing valve mobility and the mechanism of valve
obstruction. With the advent of transesophageal echocardiog-
raphy (TEE), improved definition of valve structure can be
achieved compared with the TTE approach (16,21–27).
Whether TEE can identify the etiology of valve obstruction
and differentiate thrombus from pannus formation has not
been previously evaluated. We hereby describe the clinical,
echocardiographic and TEE findings in a series of patients with
malfunctioning prosthetic valves due to pannus and/or throm-
bus formation which were documented at surgery. Clinical
findings and qualitative and quantitative echocardiographic
parameters of valvular abnormalities were evaluated to assess
their accuracy in differentiating pannus from thrombus forma-
tion.
Methods
Patient population. The study group consisted of 23 con-
secutive patients with obstruction of mechanical prosthetic
valves detected by Doppler echocardiography at the echocar-
diography laboratories of The Methodist Hospital, Houston,
Texas, or The Hippokration Hospital, Athens, Greece, who
underwent a TEE within 4 weeks prior to redo valve replace-
ment. Patients with suspected endocarditis were excluded.
There were 17 women and 6 men, with a mean age of 60 6 12
years. In the 23 patients, there were 24 malfunctioning me-
chanical prosthetic valves: 13 bileaflet St. Jude Medical valves,
7 tilting disc, 3 caged-ball and 1 caged-disc valve. All patients
had surgical and pathologic confirmation of pannus and/or
thrombus as the underlying cause of the prosthetic valve
obstruction. Demographic information, clinical data, operative
details and pathologic results were obtained from medical
records.
Echocardiographic studies. The TTE and TEE studies
were performed using commercially available ultrasound ma-
chines (Hewlett-Packard Sonos 500, 1000, 1500 and 2500
[Andover, Massachusetts or Advanced Technology Laborato-
ries [Bothell, Washington], Ultramark 9) and recorded on
videotape. A multiplane or biplane transesophageal probe
(5 MHz) was used in 14 cases, whereas a monoplane 5 MHz
probe was used in the 9 early cases, prior to biplane technol-
ogy. The TTE-Doppler studies were performed using well-
established techniques for assessment of mitral or aortic
prosthetic valve function (18,19). The TEE studies were per-
formed preoperatively and/or intraoperatively using standard
views, with particular attention directed at defining prosthetic
valve mobility, structure and presence of any mass (or masses)
on the valve and adjacent cardiac chamber. A total of 19
preoperative and 14 intraoperative TEE studies were per-
formed. In nine patients with both preoperative and intraop-
erative examinations, the intraoperative study was used as the
index TEE because of its time proximity to the surgical and
pathologic evaluation. Mean time between TTE and TEE was
2.4 days (range 0 to 21 days) and mean time between TEE and
surgery was 3.6 days (range 0 to 25 days).
Echocardiographic analysis. An observer unaware of the
surgical and pathologic findings reviewed the echocardio-
grams. From the TTE studies the following parameters were
derived. For aortic prostheses, maximum and mean gradients
(mm Hg) were calculated as well as effective aortic valve area
(cm2) and Doppler velocity index (18), that is, the ratio of
velocity in the left ventricular outflow to the velocity of the
aortic jet. For mitral prosthetic valves, mean gradient (mm
Hg), pressure half time (ms) and mitral valve area by pressure
half-time (cm2) were calculated (28,29). Ejection fraction (%)
was measured using the multiple diameter method (30). The
presence and severity of concomitant prosthetic valve regurgi-
tation were evaluated by TTE and TEE, using conventional
criteria for prosthetic aortic and mitral prostheses (23,29).
On the TEE studies, the motion of the valve was classified
as normal or abnormal depending on whether the motion of
the disc(s) or ball of the valve was normal or restricted. Any
mass seen on a prosthetic valve was assessed as follows. The
length (cm) of the mass and its area (cm2) were measured from
the view showing its largest extent. Furthermore, the length
and area of the portion of the mass within the surgical ring was
measured. Any extension of the mass beyond the limits of the
prosthetic valve ring to adjacent cardiac structures was noted.
The presence or absence of mobile portions of the mass was
also assessed. The ultrasound intensity of the mass was classi-
fied visually as soft or dense. In addition, quantitative analysis
of the videointensity was performed using computer software
(TomTec Imaging Systems, Inc., Colorado), as follows. The
area of the mass was traced and an average videointensity was
determined. The highly echogenic part of the mechanical
prosthesis was also traced and its videointensity determined.
The mechanical prosthesis was chosen as reference because of
its high ultrasound intensity and its similar depth (and gain
settings) to the mass. A videointensity ratio was subsequently
derived in each case as the ratio of the ultrasound videointen-
sity of the mass to that of the mechanical prosthetic valve.
Reproducibility. Reproducibility of the qualitative and
quantitative parameters of ultrasound intensity of the mass was
assessed in 10 randomly selected studies. These studies were
analyzed by two independent observers and by the first ob-
server at a later day. Reproducibility of Doppler derived
gradients and valve areas has been published previously from
our laboratory (18,19).
Statistical analysis. Statistical association between cate-
gorical variables in the pannus and thrombus groups were
assessed using the chi-square test or the Fisher exact test where
appropriate. The unpaired t test was used for comparisons of
means in the two groups. When the data did not follow a
Gaussian distribution, the Mann–Whitney rank sum test was
applied. Sensitivity, specificity, positive and negative predictive
values were assessed in the standard manner. A p value ,0.05
was regarded as significant.
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Results
The 24 dysfunctional valves included 10 aortic and 14 mitral
prosthetic valves. Surgical and pathologic results revealed that
the underlying cause of malfunction was thrombus in 12 cases,
pannus formation in 10 cases and a combination of thrombus
and pannus in 2 cases. Twenty-one valves had severe obstruc-
tion alone or were associated with mild or moderate regurgi-
tation, and 3 had combined severe obstruction and regurgita-
tion.
Clinical characteristics of patients with pannus versus
thrombus formation. Demographic and clinical data of pa-
tients with malfunctioning prosthetic valves due to thrombus or
pannus formation are shown in Table 1. The two patients with
combination of thrombus and pannus were included in the
thrombus group because of the inherent implication for throm-
bolytic therapy. Moreover, results were similar whether these
two patients were included or excluded. Patients with valve
thrombosis and those with pannus formation had similar age,
left ventricular ejection fraction, incidence of atrial fibrillation
and New York Heart Association functional class (Table 1).
Although functional class was overall similar at the time of
reoperation, symptoms of heart failure in patients with pannus
were more insidious. Three patients with pannus formation
were asymptomatic, and valve malfunction was diagnosed
during echocardiographic examination after abnormal auscul-
tation. The remaining patients with obstruction due to pannus
had longer duration of progression of symptoms until reopera-
tion compared to patients with thrombus. Three patients with
obstruction due to pannus had an acute deterioration of
symptoms before reoperation. The interval from valve inser-
tion to reoperation was longer in the valves with pannus
formation. Adequate anticoagulation was defined as Interna-
tional Normalized Ratio (INR) $ 2.5 at the time of diagnosis.
Eleven patients (48%) were considered to have adequate
anticoagulation, 8 in the pannus group and 3 in the thrombus
group. Of the patients with thrombosed valves, two were not
receiving coumadin and were only on antiplatelet agents and
another two had valve thrombosis after noncardiac surgery.
Adequate anticoagulation was more frequent in patients with
pannus compared to thrombus. Pannus formation was more
common in the aortic position compared to the mitral position
(70% vs. 21%, p 5 0.035).
Transthoracic echocardiographic findings: pannus versus
thrombus formation. Results of valve hemodynamics by trans-
thoracic Doppler are shown in Table 2. In general, the severity
of obstruction was similar with either pannus or thrombus
formation. Maximal and mean gradients, valve area and Dopp-
ler velocity index were similar for obstructed aortic valves by
either etiology. For mitral valves, the mean gradient was less in
patients with pannus formation, and valve areas were similar in
the two groups. Imaging with TTE was not helpful in assessing
valve motion or evaluating the underlying etiology of valve
obstruction. In only one case was TTE suggestive of a mass on
a mitral prosthesis.
Transesophageal echocardiography findings: pannus ver-
sus thrombus formation. Descriptive and quantitative find-
ings by TEE in valves with thrombus formation or pannus are
shown in Table 3. The TEE imaging revealed abnormal motion
of the disc(s) or the ball of the prosthesis in all patients with
valve thrombosis and in only six (60%) valves with obstruction
due to pannus. In three of the cases with pannus and normal
Table 1. Demographic and Clinical Parameters of Patients With
Obstructed Valves Secondary to Pannus or Thrombus Formation
Thrombus Pannus p Value
n 14 9
Age (yrs) 62 6 13 56 6 11 0.30
LVEF (%) 49 6 14 57 6 10 0.13
Atrial fibrillation 43% 33% 0.69
Time from initial onset of symptoms
to reoperation (days)
9 6 6 305 6 234 0.0006
Time from valve replacement to
reoperation (months)
62 6 57 178 6 52 0.0006
Adequate anticoagulation 21% 89% 0.0028
NYHA class III or class IV
symptoms
79% 67% 0.64
Data presented are mean value 6 SD or % of patients. LVEF 5 left
ventricular ejection fraction; NYHA 5 New York Heart Association.
Table 2. Transthoracic Echocardiographic Doppler Parameters of Malfunctioning Valves With Pannus
or Thrombus Formation
Thrombus (n 5 14) Pannus (n 5 10) p Value
Aortic Position
n 3 7
Maximum gradient (mm Hg) 83 6 18 (64–100) 101 6 27 (71–149) 0.26
Mean gradient (mm Hg) 44 6 7 (40–52) 59 6 15 (31–79) 0.077
Doppler velocity index 0.20 6 0.04 (0.16–0.24) 0.19 6 0.02 (0.15–0.22) 0.76
Valve area (cm2) 0.77 6 0.19 (0.55–0.90) 0.65 6 0.11 (0.50–0.81) 0.43
Mitral Position
n 11 3
Mean gradient (mm Hg) 19 6 5 (12–27) 11 6 2 (9–12) 0.026
Pressure half-time (ms) 310 6 61 (244–423) 223 6 40 (195–251) 0.23
Valve area (cm2) 0.73 6 0.12 (0.52–0.90) 1.0 6 0.13 (0.88–1.13) 0.28
Data are presented as mean value 6 SD and range.
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valve motion by TEE, a mass was found at surgery just below
the valve, obstructing the left ventricular outflow tract without
interfering with motion of the valve. An abnormal mass on the
prosthetic valve could be seen by TEE in 93% of thrombosed
valves and in 70% of valves with pannus formation. The TEE
imaging was unsuccessful in three cases with pannus: in an
aortic Starr–Edwards valve where pannus ingrowth was in the
form of a concentric ring just below the valve, and in two mitral
prosthetic valves (Bjo¨rk–Shiley and Cooley–Cutter) where a
small amount of pannus on the hinges of the valve was affecting
the mobility of the disc. The only thrombus which was not seen
by TEE was also small, limited to the hinges of an aortic St.
Jude Medical valve.
In the cases where a mass was detected by TEE, the shape
of the mass on the prosthetic valve did not differentiate the two
etiologies. Pannuses and thrombi were visualized as a rounded
or irregular mass in 71% and 85% of cases, respectively, and as
a thin layer (#3 mm thick) in 29% and 15%, respectively. The
presence of a mobile portion of the mass also did not differ-
entiate thrombus from pannus formation. Overall, thrombi
were larger than pannuses (Table 3, Fig. 1). The difference in
size of the mass was contributed to by the extension of the
thrombus into the left atrium in four prosthetic mitral valves
with thrombosis and in none of the mitral valves with pannus
formation (Fig. 2). A tendency was observed for the portion of
the mass confined within the surgical ring to be larger in valve
thrombosis compared to pannus formation (area: 1.7 6 1.9 vs.
1.22 6 0.63 cm2, p 5 0.41; length: 1.36 6 0.72 vs. 1.17 6
0.43 cm; p 5 0.49, respectively).
Qualitative and quantitative parameters of ultrasound in-
tensity were significantly different in thrombi compared to
pannus formation. Of the 13 thrombi detected with TEE, 12
(92%) appeared visually to have a soft echo intensity similar to
myocardium (Fig. 2), compared to 29% (2 of 7) of pannus
formation (p 5 0.007) (Figs. 3 and 4). The ultrasound video-
intensity ratio was lower for thrombi compared to pannus
(Table 3, Fig. 5). Although overlap in ultrasound intensity
existed between the two groups, the use of this quantitative
parameter allowed the use of cutoffs to improve the prediction
of either entity. The receiver-operator curve for the prediction
of thrombus formation with the ultrasound videointensity ratio
when a mass is detected on the valve by TEE (n 5 20) is shown
in Fig. 6. All thrombi had a videointensity ratio of ,0.7
(sensitivity 100%, specificity 71%). A videointensity ratio of
#0.4 was 100% specific for thrombi, while a ratio $0.7 was
100% specific for pannus formation.
Reproducibility. The interobserver and intraobserver
agreement for visual assessment of the mass as soft versus
dense was 90%. There were no statistical differences between
the videointensity ratio derived by the two observers or by the
first observer at a later day. The mean difference in ultrasound
videointensity ratio was 20.021 6 0.037 (interobserver) and
20.014 6 0.041 (intraobserver).
Prediction of thrombus formation. From a clinical stand-
point, a duration of onset of symptoms to reoperation of ,1
month separated all thrombi from pannus formation in the
present series. However, the best objective clinical parameter
Table 3. Qualitative and Quantitative Parameters by TEE in




Detection of abnormalities by TEE
Abnormal valve motion 14/14 (100%) 6/10 (60%) 0.0198
Mass visualized on valve 13/14 (93%) 7/10 (70%) 0.27
Characteristics of mass by TEE
n 13 7
Layered mass #3 mm thick 15% 29% 0.59
Mobile portion(s) of mass
present
46% 29% 0.64
Total mass area (cm2) 2.23 6 2.1 1.22 6 0.63 0.13
Total mass length (cm) 2.8 6 2.47 1.17 6 0.43 0.038
Extension of mass into LA/LAA
in prosthetic mitral valves
4/11 (36%) 0/3 (0%) 0.25
Soft ultrasound intensity 92% 29% 0.007
Ultrasound videointensity ratio 0.46 6 0.14 0.71 6 0.17 0.006
Data presented are number (%) of valves or masses, or mean value 6 SD.
LA/LAA 5 left atrium/left atrial appendage; TEE 5 transesophageal echocar-
diography.
Figure 1. Plots of total mass length (top) and total mass area (bottom)
of the 13 thrombi and 7 pannuses that were identified by TEE.
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for prediction of thrombus was inadequate anticoagulation. On
the other hand, the best TEE parameters for prediction of
thrombus were qualitative and quantitative intensity of the
mass. Table 4 shows the sensitivity, specificity and predictive
values of anticoagulation status and TEE parameters in the
prediction of thrombus formation for all 24 valves (including
those without visualization of mass on the valve by TEE). For
prediction of thrombus, the negative predictive value of inad-
equate anticoagulation was 75% and of a soft mass by TEE was
80%. This increased to 89% with a videointensity ratio of ,0.7.
The presence of either inadequate anticoagulation or a soft
mass by TEE improved the predictive power of either param-
eter alone and was similar to that of videointensity ratio.
Discussion
The present study is the first to evaluate the usefulness of
clinical and echocardiographic parameters in assessing the
etiology of prosthetic valve obstruction, namely differentiating
thrombus from pannus formation. Clinically, patients with
thrombus formation had shorter duration of symptoms to
reoperation and had more often inadequate anticoagulation.
Using TEE, a significant overlap existed between the morpho-
logic characteristics of the two etiologies. Compared to pannus
formation, thrombi were usually larger and, in the case of
mitral prostheses, extended more often into the left atrium.
The most important TEE parameter that differentiated throm-
bus from pannus was the ultrasound intensity of the mass. A
videointensity ratio of ,0.7 had the best negative predictive
value for thrombi. Similar predictive accuracy was achieved
Figure 2. Transesophageal echocardiogram showing a thrombus
(large arrows) visualized as a soft mass on the atrial side of a bileaflet
mitral prosthetic valve. There is extension of the thrombus to the left
atrial wall. Small arrows indicate the level of the prosthesis. Ao 5
aorta; PrV 5 prosthetic valve; Th 5 thrombus.
Figure 3. Transesophageal echocardiogram showing a pannus (large
arrows) visualized as a dense mass on a tilting-disc aortic prosthesis.
Small arrow indicates the valve ring. LA 5 left atrium; LV 5 left
ventricle; Pn 5 pannus; PrV 5 prosthetic valve.
Figure 4. Transesophageal echocardiogram showing a pannus (arrow)
visualized as a soft mass on a bileaflet aortic prosthesis. LA 5 left
atrium; Pn 5 pannus.
Figure 5. Plots of the ultrasound videointensity ratio in the 13 thrombi
and 7 pannuses that were visualized by TEE.
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with the combination of inadequate anticoagulation or the
presence of a soft mass by TEE.
Differentiating thrombus from pannus formation. The in-
cidence of prosthetic valve obstruction has been recently
estimated at 0.1% to 4% per year, and is dependent on several
factors including valve size, type and location, and adequacy of
anticoagulation (1). The underlying etiology of prosthetic valve
obstruction is most commonly thrombus formation (5–8). In a
study by Deviri et al. (8) evaluating the surgical findings of 112
obstructed mechanical valves, pannus formation was the un-
derlying cause in 10.7% of valves, pannus in combination with
thrombus was present in 11.6%, whereas thrombus alone or
with little pannus formation was found in 77.7%. The predic-
tion of thrombus formation as the predominant mechanism of
obstruction has important clinical implications because throm-
bolytic therapy has recently emerged as an alternative to
reoperation (9–15). A high negative predictive value for
thrombus would allow detection of most thrombi and therefore
identify patients with pannus formation who can forgo at-
tempts at thrombolytic therapy and undergo immediate valve
surgery, particularly when presenting with hemodynamic insta-
bility.
Among clinical variables affecting the incidence of throm-
bus formation, long-term anticoagulation is the most im-
portant (1,2,8,11,13–15). In patients with valve obstruction
requiring reoperation or thrombolytic therapy, inadequate
anticoagulation has been reported between 48% and 92%
(2,8,11,13,14). In the only case series that has related the
adequacy of anticoagulation to pathologic findings, 48% (13 of
27) of patients with prosthetic valve obstruction secondary to
thrombus had inadequate anticoagulation (2). There are no
reports in the literature assessing the level of anticoagulation
in patients with pannus formation. In the present study,
suboptimal anticoagulation was present in 78% of valve throm-
bosis and in only 11% of pannus formation, further confirming
the clinical suspicion that patients with valve obstruction in the
setting of therapeutic anticoagulation are more likely to have
pannus formation.
Time from valve insertion to malfunction was longer in
patients with pannus. A period of 6 months or longer after
implantation is usually needed for tissue overgrowth in a
mechanical prosthesis (5,6), although a shorter time interval
from valve replacement has been reported (7). In the present
study the minimum time was 12 months in a valve with a
combination of pannus and thrombus and 78 months in a valve
with sole pannus formation. In addition, patients with throm-
bus had a shorter duration from onset of symptoms to reop-
eration. This finding is in agreement with observations by
Silber et al. (14). However, Kontos et al. (2) have reported
more prolonged symptoms in patients with malfunctioning
prosthetic valves due to thrombus formation (56% had symp-
toms for more than a month before reoperation). There is
currently no information about the duration of symptoms in
patients with valve obstruction due to pannus formation. In our
population, six patients had progression of symptoms from 1
month to 2 years, three of whom had acute deterioration a few
days prior to reoperation, while another three patients were
asymptomatic. The patient with the longest duration of symp-
toms had two malfunctioning prosthetic valves due to pannus,
but also had severe tricuspid regurgitation, which could have
contributed to his symptomatology. Overall, the prolonged
duration of symptoms in patients with valve obstruction due to
pannus formation may reflect the long, slow process of pannus
growth until a severe subvalvular obstruction is created or the
valve mechanism is blocked. Although duration of heart failure
symptoms prior to reoperation was seemingly the best param-
eter in differentiating the two etiologies in the present series, it
is subjective, determined by the timing of the intervention, and
may be confounded by the presence of ventricular dysfunction
or other valvular lesions (2). Furthermore, this parameter is
not a predictor of successful thrombolysis (11,13,14). Among
more objective clinical variables, adequacy of anticoagulation
differentiated best between patients with thrombus and pannus
formation.
Figure 6. Receiver-operator curve for prediction of thrombus using
the ultrasound videointensity ratio. UVI 5 ultrasound videointensity.
Table 4. Sensitivity, Specificity and Predictive Accuracy of
Inadequate Anticoagulation and TEE Parameters for Prediction of









Inadequate anticoagulation 79 90 92 75
Soft mass by TEE 86 80 86 80
UVI ratio ,0.70 93 80 87 89
Inadequate anticoagulation
or soft mass by TEE
93 80 87 89
Inadequate anticoagulation
or UVI ratio ,0.70
93 80 87 89
NP 5 negative predictive; PP 5 positive predictive; TEE 5 transesophageal
echocardiography; UVI 5 ultrasound videointensity.
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Transthoracic and transesophageal echocardiographic
findings. Transthoracic echocardiography is limited in evalu-
ating structural abnormalities of prosthetic valves because of
attenuation and acoustic shadowing (16,21–27). This was fur-
ther supported in the present investigation where only one
valve was suspicious of a thrombus by TTE. In contrast, TEE
provides a unique tool to assess valvular details. In 83% of
obstructed valves, an abnormal structure on the prosthesis was
detected. In the cases where TEE failed to identify an etiology,
it was more often a small mass, usually pannus, interfering with
the hinges of the prosthesis.
The TEE examination showed that thrombi leading to valve
obstruction were overall larger than pannuses. In mitral valves,
extension of the mass into the left atrium was specific for
thrombus formation but occurred in 36% of cases. Other
characteristics of the mass, such as features of a thin layer, the
presence of mobile portions or its size alone, did not ade-
quately differentiate between the two etiologies. The ultra-
sound intensity of the mass imaged by TEE, however, helped
differentiate pannus from thrombus. A structure with soft
echodensity, similar to myocardium, was more often seen with
thrombus. Quantitative assessment of the echo intensity by the
ultrasound videointensity ratio slightly improved the differen-
tiation between pannus and thrombus but importantly pro-
vided an objective and quantitative parameter for ultrasound
intensity and allowed the use of cutoff values to enhance
prediction of either entity. A videointensity ratio ,0.7 had the
best negative predictive value (89%) for thrombi compared to
all other parameters, which increased to 100% in valves where
a mass was identified by TEE. The combination of inadequate
anticoagulation or a low ultrasound intensity of the mass by
TEE (qualitatively or quantitatively) achieved the same pre-
dictive accuracy compared with videointensity ratio alone.
Although this may provide redundant information, it would
further strengthen the clinical diagnosis and may improve the
selection of patients for thrombolysis or redo valve surgery.
Whether these parameters help predict the success of throm-
bolysis and the merit of quantitation of ultrasound intensity of
the mass in this prediction remains to be determined.
Study limitations. The present study is retrospective and
pathologic data were obtained from medical records. Although
the different kinds of prostheses evaluated may potentially be
a limitation, this allows testing the usefulness of TEE in a
variety of mechanical valves. Requirement of a recent TEE
prior to surgery and exclusion of patients who underwent
thrombolysis limited the number of patients studied, but
allowed evaluation of the usefulness of TEE in this condition.
Studies were performed with a multiplane or biplane TEE
probe in the majority of patients; the remaining patients were
evaluated prior to this technology. However, every attempt to
modify plane position in addition to side flexion was per-
formed. It is of interest that two of the four nonvisualized
etiologies of valve obstruction (one aortic and one mitral) had
multiplane studies. Ultrasound intensity was assessed qualita-
tively and quantitatively. Limitations of videodensitometry
include, among others, gain dependency and logarithmic com-
pression. The videointensity ratio attempts to normalize the
ultrasound intensity in an image, where gains are usually
optimized for identification of cardiac structures. Qualitative
assessment of ultrasound intensity related well to this quanti-
tative index, which provided a more objective parameter of
ultrasound intensity.
Conclusions. In obstructed mechanical prosthetic valves,
duration of symptoms and adequacy of anticoagulation are
helpful in differentiating thrombus from pannus formation.
The use of TEE can assess the mechanism and etiology of
obstruction. Thrombus is overall larger than pannus and often
extends into the left atrium in prosthetic mitral valves. The best
parameter by TEE that differentiates the two entities is the
ultrasound intensity of the mass. The combination of clinical
parameters and ultrasound density of the mass by TEE further
strengthens the differentiation of thrombi from pannus forma-
tion and may therefore be of value in refining the selection of
patients for thrombolysis. Whether TEE can further improve
the safety of thrombolysis of prosthetic valve thrombosis by
selecting patients with small, nonmobile thrombi remains to be
determined.
The authors thank Ms. Eula Landry for her expert secretarial assistance in the
preparation of the manuscript.
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